Nicoya is a pioneering company at the forefront of democratizing scientific exploration through groundbreaking advancements in microfluidics and nanotechnology. Committed to making cutting-edge label-free surface plasmon resonance (SPR) technology accessible to scientists across disciplines, Nicoya specializes in miniaturizing biomolecular binding analysis, with the aim to simplify experiments by automating user operation, reducing sample sizes by more than 100-fold, and eliminating bulky and complex instrumentation, ultimately providing researchers with cost-effective and easy-to-use tools. At Nicoya, our commitment to making technology more accessible drives us to empower scientists globally, fostering a new era of exploration and innovation.
